KinATLAS
TranscriptoNET
PhosphoNET
OncoNET
KinaseNET
DrugKiNET
KiNET-AM
Kinetica Online
Search by protein name, UniProt number, IPI number, or 15 AA P-site sequence.
Updated: 2017 Aug. 1
|
Home
|
Kinexus
|
Contact
|
Credits
Note
- Blast analyses are based on comparisons of the phosphosites and the bordering four amino acids on each side of these phosphosites.
Phosphosite
Human Protein:
FBXW7
Human P-Site:
S191
P-Site Sequence:
GKKPCKV
S
EYTSTTG
UniProt:
Q969H0
Intern. Prot. ID:
IPI00056349
Protein Phosphosite
Match
Human Protein
Short Name
Human
UniProt. ID
Phosphosite
Number
Sequence
% Identity / # AA
Target Size kDa
Phosphosite 0:
FBXW7
Q969H0
S191
GKKPCKVSEYTSTTG
100 / 9 AA
80
Phosphosite 1:
FBXW7
Q969H0
Y193
KPCKVSEYTSTTGLV
100 / 7 AA
80
Phosphosite 2:
STARD9
Q9P2P6
S4005
HLSPCPVSELTDTAG
75 / 8 AA
507
Phosphosite 3:
FRMPD2
Q68DX3
S235
CLHPCRVSERSTETQ
83 / 6 AA
144
Phosphosite 4:
MRI
Q9BWK5
S99
HSPPCSVSPHTSSGS
66 / 9 AA
17
Phosphosite 5:
UNC93A
Q86WB7
Y316
LYGKVSQYTGRAVLY
71 / 7 AA
50
Phosphosite 6:
AFF2
P51816
Y60
EPYKVAEYTNKGDAL
71 / 7 AA
145
Phosphosite 7:
EphB1
P54762
S761
SNLVCKVSDFGLSRY
66 / 6 AA
110
Phosphosite 8:
FNDC3B
Q53EP0
S704
SESGCEVSEYSVEMT
71 / 7 AA
133
Phosphosite 9:
Ig heavy chain V-I region V35
P23083
S44
VKVSCKASGYTFTGY
62 / 8 AA
13
Phosphosite 10:
Ig heavy chain V-I region HG3
P01743
S44
VKVSCKASGYTFNSY
62 / 8 AA
13
Phosphosite 11:
VSIG7
A6NDP1
S44
VRISCKASGYTFTSY
62 / 8 AA
13
Phosphosite 12:
Putative V-set and immunoglobulin domain-containing-like protein ENSP00000303034
A6NJS3
S44
VKVSCKASGYTITSY
62 / 8 AA
13
Phosphosite 13:
UNC93A
Q86WB7
S314
SVLYGKVSQYTGRAV
71 / 7 AA
50
Phosphosite 14:
PLCL1
Q15111
Y872
MGKKVREYTMLRNIG
83 / 6 AA
123
Phosphosite 15:
SPDYC
Q5MJ68
S104
QRAHLKLSEYTHSSL
83 / 6 AA
33
Phosphosite 16:
MEKK2
Q9Y2U5
S587
PKLPPHVSDYTRDFL
62 / 8 AA
70
Phosphosite 17:
PMS1
P54277
S529
KSLPCKVSNNNYPIP
83 / 6 AA
106
Phosphosite 18:
GOLGA4
Q13439
S1172
EEDKRKVSELTSKLK
75 / 8 AA
261
Phosphosite 19:
IMPDH2
P12268
Y353
AVYKVSEYARRFGVP
71 / 7 AA
56
Phosphosite 20:
ZNF80
P51504
S192
GEKPCKCSECGKTFT
71 / 7 AA
31